Clorox (NYSE:CLX – Get Free Report) issued an update on its FY25 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $6.55-$6.80 for the period, compared to the consensus estimate of $6.48. The company issued revenue guidance of $6.95-$7.09 billion, compared to the consensus revenue estimate of $7.32 billion. Clorox also updated its FY 2025 guidance to 6.550-6.800 EPS.
Clorox Trading Up 7.4 %
NYSE CLX traded up $9.95 on Friday, hitting $144.09. The company’s stock had a trading volume of 2,902,055 shares, compared to its average volume of 1,222,022. Clorox has a 52-week low of $114.68 and a 52-week high of $169.14. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The company’s 50-day simple moving average is $133.90 and its 200 day simple moving average is $142.39. The firm has a market cap of $17.89 billion, a P/E ratio of 74.66, a PEG ratio of 1.97 and a beta of 0.39.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 382.58% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Research analysts predict that Clorox will post 6.4 EPS for the current fiscal year.
Clorox Increases Dividend
Analyst Ratings Changes
A number of brokerages have issued reports on CLX. Argus upgraded Clorox to a hold rating in a research note on Tuesday, June 4th. Wells Fargo & Company lowered their price objective on Clorox from $135.00 to $130.00 and set an underweight rating for the company in a research note on Wednesday, July 10th. UBS Group lowered their price objective on Clorox from $164.00 to $159.00 and set a neutral rating for the company in a research note on Wednesday, May 1st. Deutsche Bank Aktiengesellschaft lifted their target price on Clorox from $144.00 to $151.00 and gave the stock a hold rating in a report on Friday. Finally, TD Cowen assumed coverage on Clorox in a report on Tuesday, July 23rd. They issued a sell rating and a $122.00 target price for the company. Six analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of Hold and a consensus target price of $141.44.
View Our Latest Analysis on Clorox
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- What is the NASDAQ Stock Exchange?
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- What is the FTSE 100 index?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- How to Read Stock Charts for Beginners
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.